B

BLIS Technologies
BLT

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
NZ$24.31M
EV
NZ$15.24M
Shares Outstanding
1.28B
Beta
0.29

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E 2026E
-
P/Revenue 2026E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About BLIS Technologies Limited

gainify

B

BLIS Technologies Limited

BLT

BLIS Technologies Limited, together with its subsidiaries, develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity. The company offers BLIS K12, an oral probiotic supplement to support ear, nose, and throat health, as well...

Sector

Healthcare

Industry

Biotechnology

CEO

Johnson, Scott

Employees

38

IPO Date

2001-07-29

Headquarters

399 Moray Place, Dunedin 9016, New Zealand

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.